Precision Strategies for Solid Tumor Resistance
Contents
Moderator
Dr. Shuai Ren
Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, Jiangsu, China.
Scopus: https://www.scopus.com/pages/authors/57195058841
Research Interest: Gastrointestinal tumors, nanodrug delivery, tumor immunology, exosomes, extracellular vesicles, molecular probes
Research Interest: Gastrointestinal tumors, nanodrug delivery, tumor immunology, exosomes, extracellular vesicles, molecular probes
Speaker(s)
Prof. Martin Michaelis
University of Kent, Canterbury, United Kingdom.
Scopus: https://www.scopus.com/pages/authors/34571115900
Research Interest: Drugs and mechanisms of action, acquired drug resistance in cancer, therapeutic targets
Research Interest: Drugs and mechanisms of action, acquired drug resistance in cancer, therapeutic targets
Dr. Yuxuan Song
Peking University People's Hospital, Beijing, China.
Scopus: https://www.scopus.com/pages/authors/57203822723
Research Interest: Urologic cancers, spatiotemporal multi-omics, organoids, immunotherapy, large language models (LLMs)
Research Interest: Urologic cancers, spatiotemporal multi-omics, organoids, immunotherapy, large language models (LLMs)
Prof. Nadia M. Hamdy
Ain Shams University, Cairo, Egypt.
Scopus: https://www.scopus.com/authid/detail.uri?authorId=57190847144
Research Interest: Non-coding RNAs (lncRNA/miRNA/piRNA/circRNAs), epigenetic regulation in cancer, tumor microenvironment, targeted therapy and precision oncology, signaling pathways in cancer, biomarkers for diagnosis and prognosis, translational cancer therapeutics
Research Interest: Non-coding RNAs (lncRNA/miRNA/piRNA/circRNAs), epigenetic regulation in cancer, tumor microenvironment, targeted therapy and precision oncology, signaling pathways in cancer, biomarkers for diagnosis and prognosis, translational cancer therapeutics
